Pankreatin Mikro Pankreas-Pulver Vom Schwein Ratiopharm (Pancreas Powder From Porcine)

Pankreatin Mikro acts on the digestive system to replace deficient pancreatic enzymes in several clinical situations.

• Exocrine pancreatic insufficiency: improves nutrient absorption and reduces steatorrhea.
• Cystic fibrosis related pancreatic insufficiency: aids digestion of fats and proteins.
• Post‑surgical pancreatic resection: assists in maintaining adequate digestion after loss of pancreatic tissue.

• The porcine pancreas powder contains a mixture of lipase, amylase and protease enzymes that hydrolyze triglycerides, starches and proteins respectively. By supplying these enzymes directly into the gastrointestinal tract, the preparation compensates for the body’s reduced endogenous pancreatic secretion, facilitating normal macronutrient digestion and absorption.

Adverse reactions may occur with any pancreatic enzyme preparation and should be monitored during therapy.

Common Side Effects

• Abdominal discomfort: mild cramping or bloating.
• Flatulence: increased intestinal gas.
• Nausea: occasional feeling of queasiness.
• Diarrhea: loose stools, often transient.
• Constipation: reduced bowel movements.
• Skin irritation at the site of powder handling.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Pancreatitis flare: worsening abdominal pain.
• Severe hypocalcemia: low calcium levels, especially with high‑dose use.
• Fungal overgrowth: oral or gastrointestinal candidiasis.
• Persistent vomiting or severe diarrhea leading to dehydration.

When prescribing Pankreatin Mikro, clinicians should consider several safety aspects.

• Assess pancreatic function: confirm exocrine insufficiency before initiation.
• Monitor nutritional status: track weight, fat-soluble vitamin levels and stool fat content.
• Adjust dose gradually: avoid abrupt high doses that may cause gastrointestinal upset.
• Review concomitant medications: some acid‑reducing agents can affect enzyme activity.
• Pregnancy and lactation: use only if the benefit outweighs potential risk.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pancreatic enzyme powders can interact with other medicines by altering gastric pH or competing for absorption.

Major Interactions (Avoid)

• Proton pump inhibitors: may reduce enzyme activation, diminishing therapeutic effect.
• Antacids containing aluminum or magnesium: can bind enzymes and lower efficacy.

Moderate Interactions (Monitor Closely)

• Oral corticosteroids: may increase risk of gastrointestinal irritation.
• Warfarin: rare reports of altered INR, requiring periodic monitoring.
• Antibiotics (e.g., clindamycin): potential for overgrowth of resistant organisms when enzyme therapy changes gut flora.